- Home
- LNSR
LNSR
LENSAR Inc.
as of 12-02-2025 12:04pm EST
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe and Asia.
| Founded: | 2004 | Country: | United States |
| Employees: | N/A | City: | ORLANDO |
| Market Cap: | 142.0M | IPO Year: | N/A |
| Target Price: | $15.00 | AVG Volume (30 days): | 75.5K |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -4.35 | EPS Growth: | N/A |
| 52 Week Low/High: | $7.13 - $17.31 | Next Earning Date: | 11-06-2025 |
| Revenue: | $59,141,000 | Revenue Growth: | 21.02% |
| Revenue Growth (this year): | 30.8% | Revenue Growth (next year): | 33.09% |
AI-Powered LNSR Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Compare LNSR vs Leading Stocks
See how LNSR stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "LNSR LENSAR Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.